[
    {
        "molecule_name": "peptide Arg<sup>5</sup>",
        "protein_target_name": "NMB receptor",
        "binding_metric": "K<sub>i</sub>",
        "value": "47.4 ± 10.3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nExamples of the NMB receptor binding assay results for three analogs of the invention were (K<sub>i</sub> values in nM) 47.4 ± 10.3 (peptide Arg<sup>5</sup>), and 85.1 ± 2.7 (peptide Dab<sup>5</sup>).\nExamples of the GRP receptor binding assay results for analogs of the invention were (K<sub>i</sub> values in nM) 2921 ± 250 (peptide Arg<sup>5</sup>) and 2632 ± 216 (peptide Dab<sup>5</sup>).\nA known cyclic octapeptide D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>) was disclosed in Orbuch et al., Mol. Pharmacol. 44:841 (1993), and had an extremely high affinity for the somatostatin receptor (K<sub>i</sub> = 0.84 ± 0.53).\nK<sub>i</sub> values (nM) for analogs of the invention were 407 ± 82 (peptide D"
    },
    {
        "molecule_name": "peptide Dab<sup>5</sup>",
        "protein_target_name": "NMB receptor",
        "binding_metric": "K<sub>i</sub>",
        "value": "85.1 ± 2.7",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nExamples of the NMB receptor binding assay results for three analogs of the invention were (K<sub>i</sub> values in nM) 47.4 ± 10.3 (peptide Arg<sup>5</sup>), and 85.1 ± 2.7 (peptide Dab<sup>5</sup>).\nExamples of the GRP receptor binding assay results for analogs of the invention were (K<sub>i</sub> values in nM) 2921 ± 250 (peptide Arg<sup>5</sup>) and 2632 ± 216 (peptide Dab<sup>5</sup>).\nA known cyclic octapeptide D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>) was disclosed in Orbuch et al., Mol. Pharmacol. 44:841 (1993), and had an extremely high affinity for the somatostatin receptor (K<sub>i</sub> = 0.84 ± 0.53).\nK<sub>i</sub> values (nM) for analogs of the invention were 407 ± 82 (peptide D"
    },
    {
        "molecule_name": "peptide Arg<sup>5</sup>",
        "protein_target_name": "GRP receptor",
        "binding_metric": "K<sub>i</sub>",
        "value": "2921 ± 250",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nExamples of the NMB receptor binding assay results for three analogs of the invention were (K<sub>i</sub> values in nM) 47.4 ± 10.3 (peptide Arg<sup>5</sup>), and 85.1 ± 2.7 (peptide Dab<sup>5</sup>).\nExamples of the GRP receptor binding assay results for analogs of the invention were (K<sub>i</sub> values in nM) 2921 ± 250 (peptide Arg<sup>5</sup>) and 2632 ± 216 (peptide Dab<sup>5</sup>).\nA known cyclic octapeptide D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>) was disclosed in Orbuch et al., Mol. Pharmacol. 44:841 (1993), and had an extremely high affinity for the somatostatin receptor (K<sub>i</sub> = 0.84 ± 0.53).\nK<sub>i</sub> values (nM) for analogs of the invention were 407 ± 82 (peptide D"
    },
    {
        "molecule_name": "peptide Dab<sup>5</sup>",
        "protein_target_name": "GRP receptor",
        "binding_metric": "K<sub>i</sub>",
        "value": "2632 ± 216",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nExamples of the NMB receptor binding assay results for three analogs of the invention were (K<sub>i</sub> values in nM) 47.4 ± 10.3 (peptide Arg<sup>5</sup>), and 85.1 ± 2.7 (peptide Dab<sup>5</sup>).\nExamples of the GRP receptor binding assay results for analogs of the invention were (K<sub>i</sub> values in nM) 2921 ± 250 (peptide Arg<sup>5</sup>) and 2632 ± 216 (peptide Dab<sup>5</sup>).\nA known cyclic octapeptide D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>) was disclosed in Orbuch et al., Mol. Pharmacol. 44:841 (1993), and had an extremely high affinity for the somatostatin receptor (K<sub>i</sub> = 0.84 ± 0.53).\nK<sub>i</sub> values (nM) for analogs of the invention were 407 ± 82 (peptide D"
    },
    {
        "molecule_name": "D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>)",
        "protein_target_name": "somatostatin receptor",
        "binding_metric": "K<sub>i</sub>",
        "value": "0.84 ± 0.53",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nExamples of the NMB receptor binding assay results for three analogs of the invention were (K<sub>i</sub> values in nM) 47.4 ± 10.3 (peptide Arg<sup>5</sup>), and 85.1 ± 2.7 (peptide Dab<sup>5</sup>).\nExamples of the GRP receptor binding assay results for analogs of the invention were (K<sub>i</sub> values in nM) 2921 ± 250 (peptide Arg<sup>5</sup>) and 2632 ± 216 (peptide Dab<sup>5</sup>).\nA known cyclic octapeptide D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> (Lys<sup>5</sup>) was disclosed in Orbuch et al., Mol. Pharmacol. 44:841 (1993), and had an extremely high affinity for the somatostatin receptor (K<sub>i</sub> = 0.84 ± 0.53).\nK<sub>i</sub> values (nM) for analogs of the invention were 407 ± 82 (peptide D"
    }
]